Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Nov 15, 2022 12:08pm
96 Views
Post# 35100250

RE:Soleus influence?

RE:Soleus influence?

They aren't known as an "activist" fund, but that doesn't mean they are 100% passive either, especially with an investment that is in their top 10 holdings.  I am sure they are on top of it and are 100% motivated to make the best of the science driving their return. Unlike VC firms, I don't think they've always taken Board seats, but perhaps they have when they get involved at the private stage, which they have done with other companies in the past.  I would love to see a  top financially motivated shareholder on the Board, but it does stifle some of the actions they are free to do as non-insiders. 


Lee430 wrote: Any thoughts on how Soleus might choose to influence Thera with over 10% ownership? Possibly push for more IR effort toward increasing shareholder value.

 

<< Previous
Bullboard Posts
Next >>